Business
Result of EGM
Result of EGM.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n Aortech International PLC\n20 August 2007\n\n\n\n20 August 2007\n\n\n\n AorTech International plc ('AorTech' or the 'Company')\n\n Result of Extraordinary General Meeting\n\n\nAorTech International (AIM:AOR), the biomaterials and medical device development\ncompany, held its Extraordinary General Meeting today at which all resolutions\nwere passed.\n\n\n - Ends -\n\n\n\nFor further information please contact:\n\nAorTech International plc Tel: + 1 801 201 4336\nFrank Maguire, Chief Executive\n\nEvolution Securities Tel: +44 20 7071 4300\nBobbie Hilliam\nTim Worlledge\n\nHogarth Partnership Limited Tel: +44 20 7357 9477\nMelanie Toyne-Sewell\nSarah Richardson\n\n\n\nNotes to Editors:\n\nAbout AorTech International plc\n\nListed on AIM in London, AorTech International plc wholly owns AorTech\nBiomaterials based in Melbourne, Australia. AorTech Biomaterials was formed in\nJuly 1997 to commercialise a range of medical grade polyurethanes for medical\nimplants developed by the Commonwealth Scientific and Industrial Research\nOrganisation (CSIRO).\n\nAorTech's Elast-Eon technology is the product of a decade of fundamental\nresearch into biologically stable materials. Elast-Eon materials are patented,\nhigh silicone content, polyurethane copolymers which exhibit unparalleled\nbiological and mechanical performance.\n\nAorTech is firmly focused on the development and refinement of this material for\nthe medical community, with the aim of providing a wide range of high\nperformance Elast-Eon materials in a variety of application specific\nformulations and densities, for use in medical devices.\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n \n ","length":2058,"tagName":"div"}]